Cargando…

Using rapid point-of-care tests to inform antibiotic choice to mitigate drug resistance in gonorrhoea

BACKGROUND: The first cases of extensively drug resistant gonorrhoea were recorded in the United Kingdom in 2018. There is a public health need for strategies on how to deploy existing and novel antibiotics to minimise the risk of resistance development. As rapid point-of-care tests (POCTs) to predi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vegvari, Carolin, Grad, Yonatan H, White, Peter J, Didelot, Xavier, Whittles, Lilith K, Scangarella-Oman, Nicole E, Mitrani-Gold, Fanny S, Dumont, Etienne, Perry, Caroline R, Gilchrist, Kim, Hossain, Mohammad, Mortimer, Tatum D, Anderson, Roy M, Gardiner, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596916/ https://www.ncbi.nlm.nih.gov/pubmed/33124551 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.43.1900210

Ejemplares similares

A dynamic power-law sexual network model of gonorrhoea outbreaks
por: Whittles, Lilith K., et al.
Publicado: (2019)

Epidemiological Trends of Antibiotic Resistant Gonorrhoea in the United Kingdom
por: Whittles, Lilith K., et al.
Publicado: (2018)

A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on Neisseria gonorrhoeae antimicrobial resistance
por: Mortimer, Tatum D., et al.
Publicado: (2023)

Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study
por: Whittles, Lilith K., et al.
Publicado: (2017)

Public health impact and cost-effectiveness of gonorrhoea vaccination: an integrated transmission-dynamic health-economic modelling analysis
por: Whittles, Lilith K, et al.
Publicado: (2022)

Dose selection for a phase III study evaluating gepotidacin (GSK2140944) in the treatment of uncomplicated urogenital gonorrhoea
por: Scangarella-Oman, Nicole E, et al.
Publicado: (2023)

Efflux Pump Antibiotic Binding Site Mutations Are Associated with Azithromycin Nonsusceptibility in Clinical Neisseria gonorrhoeae Isolates
por: Ma, Kevin C., et al.
Publicado: (2020)

Loci for prediction of penicillin and tetracycline susceptibility in Neisseria gonorrhoeae: a genome-wide association study
por: Mortimer, Tatum D, et al.
Publicado: (2022)

Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study
por: Rubin, Daniel H F, et al.
Publicado: (2023)

Epidemiological analysis of the Eyam plague outbreak of 1665–1666
por: Whittles, Lilith K., et al.
Publicado: (2016)

RNA polymerase mutations cause cephalosporin resistance in clinical Neisseria gonorrhoeae isolates
por: Palace, Samantha G, et al.
Publicado: (2020)

Increased power from conditional bacterial genome-wide association identifies macrolide resistance mutations in Neisseria gonorrhoeae
por: Ma, Kevin C., et al.
Publicado: (2020)

Model-based analysis of an outbreak of bubonic plague in Cairo in 1801
por: Didelot, Xavier, et al.
Publicado: (2017)

Efficacy, Safety, and Tolerability of Gepotidacin (GSK2140944) in the Treatment of Patients with Suspected or Confirmed Gram-Positive Acute Bacterial Skin and Skin Structure Infections
por: O'Riordan, William, et al.
Publicado: (2017)

The Distribution and Spread of Susceptible and Resistant Neisseria gonorrhoeae Across Demographic Groups in a Major Metropolitan Center
por: Mortimer, Tatum D, et al.
Publicado: (2020)

Microbiological Analysis from a Phase 2 Randomized Study in Adults Evaluating Single Oral Doses of Gepotidacin in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria gonorrhoeae
por: Scangarella-Oman, Nicole E., et al.
Publicado: (2018)

1698. Trends in antimicrobial resistance among outpatient urine E. coli isolates in US females ≥12 years of age: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

1699. Variation of antimicrobial resistance by age groups for outpatient UTI isolates in US females: A multicenter evaluation from 2011 to 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

187. Regional Distribution of Antimicrobial Resistance Among Outpatient Urine e. Coli Isolates in US Females ≥12 Years of age: a Multicenter Evaluation in 2019
por: Kaye, Keith S, et al.
Publicado: (2020)

Assessment of the Potential of Vaccination to Combat Antibiotic Resistance in Gonorrhea: A Modeling Analysis to Determine Preferred Product Characteristics
por: Whittles, Lilith K, et al.
Publicado: (2020)

1482. Microbiological Analysis from a Phase II Study Evaluating Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections
por: Scangarella-Oman, Nicole, et al.
Publicado: (2019)

1480. Plasma and Urine Pharmacokinetic Analysis of Gepotidacin (GSK2140944) Following BID Oral Dosing in a Phase IIa Study for Treatment of Uncomplicated Urinary Tract Infections
por: Zimmerman, Eric I, et al.
Publicado: (2019)

1479. Clinical Efficacy and Safety Analysis Evaluating Oral Gepotidacin (GSK2140944) from a Phase IIa Study in the Treatment of Uncomplicated Urinary Tract Infections
por: Overcash, J Scott, et al.
Publicado: (2019)

Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management
por: Kaye, Keith S, et al.
Publicado: (2021)

2225. Analysis of Co-Resistance Among Escherichia coli Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022)

2226. Analysis of Co-Resistance Among Klebsiella pneumoniae Urine Isolates From Female Outpatients in the United States
por: Kaye, Keith S, et al.
Publicado: (2022)

Interactions between Loci Contributing to Antimicrobial Resistance and Virulence in Neisseria gonorrhoeae
por: Mortimer, Tatum D.
Publicado: (2022)

1281. Longitudinal and Spatial Variation in the Human Microbiome in a Phase 2a Clinical Study of Gepotidacin in Adult Females with Uncomplicated Urinary Tract Infection
por: Nuzzo, Andrea, et al.
Publicado: (2020)

Dose Selection for Phase III Clinical Evaluation of Gepotidacin (GSK2140944) in the Treatment of Uncomplicated Urinary Tract Infections
por: Scangarella-Oman, Nicole E., et al.
Publicado: (2022)

Design of Two Phase III, Randomized, Multicenter Studies Comparing Gepotidacin with Nitrofurantoin for the Treatment of Uncomplicated Urinary Tract Infection in Female Participants
por: Perry, Caroline, et al.
Publicado: (2022)

Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae
por: Ma, Kevin C., et al.
Publicado: (2020)

Correction to: Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK2140944)
por: Nuzzo, Andrea, et al.
Publicado: (2021)

Microbiome recovery in adult females with uncomplicated urinary tract infections in a randomised phase 2A trial of the novel antibiotic gepotidacin (GSK140944)
por: Nuzzo, Andrea, et al.
Publicado: (2021)

1249. Genetic Evidence That Gepotidacin Shows Well-balanced Dual Targeting against DNA Gyrase And Topoisomerase IV in Neisseria gonorrhoeae
por: Chan, Pan, et al.
Publicado: (2020)

Older patient age and prior antimicrobial use strongly predict antimicrobial resistance in Escherichia coli isolates recovered from urinary tract infections among female outpatients
por: Mitrani-Gold, Fanny S., et al.
Publicado: (2023)

Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae
por: Yahara, Koji, et al.
Publicado: (2021)

Phase 2a Pharmacokinetic, Safety, and Exploratory Efficacy Evaluation of Oral Gepotidacin (GSK2140944) in Female Participants with Uncomplicated Urinary Tract Infection (Acute Uncomplicated Cystitis)
por: Overcash, J. Scott, et al.
Publicado: (2020)

Disseminated Gonococcal Infection Complicated by Prosthetic Joint Infection: Case Report and Genomic and Phylogenetic Analysis
por: Ogbebor, Osakpolor, et al.
Publicado: (2020)

A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch
por: Sánchez-Busó, Leonor, et al.
Publicado: (2021)

Draft Genome Sequences of Three Penicillin-Resistant Neisseria gonorrhoeae Strains Isolated in Cincinnati, Ohio, in 1994
por: Murphy, Thomas C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2e533462ealluf3ks3k0cm45v6